市場調查報告書
商品編碼
1467852
2024-2032 年按交付模式、組件、開發階段、最終用戶和地區分類的電子資料收集系統市場報告Electronic Data Capture Systems Market Report by Delivery Mode, Component, Development Phase, End User, and Region 2024-2032 |
IMARC Group年全球電子資料採集(EDC)系統市場規模達13億美元。臨床試驗的快速數位化、雲端系統的日益普及以及行動 EDC 的引入是推動市場發展的一些關鍵因素。
電子資料擷取(EDC)系統是指設計用於以電子格式收集和管理臨床試驗資料的軟體工具。它們捕捉各種各樣的資料,包括患者人口統計、病史、不良事件、實驗室結果、臨床結果評估、電子知情同意書 (eConsent) 和研究中心資訊。 EDC 系統被監管機構、臨床試驗申辦者、合約研究組織 (CRO)、試驗參與者和資料管理者廣泛使用。它們有助於簡化資料收集、提高資料品質、最大限度地減少人為錯誤、保護敏感資訊並降低資料遺失和重複的風險。 EDC系統還提高臨床試驗的效率,提供即時監測能力,輔助決策,並確保資料的準確性、可靠性和一致性。
全球臨床試驗的快速數位化是推動市場成長的主要因素之一。 EDC系統廣泛用於自動化各種臨床試驗操作,例如資料收集、儲存、監控和分析,從而加速流程、提供透明度、防止錯誤並提高整體效率。除此之外,由於糖尿病、高血壓、阿茲海默症、多發性硬化症和心血管疾病(CVD)等慢性病的盛行率不斷增加,對新療法和療法的需求不斷成長,也是另一個生長誘導因素。此外,基於雲端的系統的日益普及,具有成本效益、方便用戶使用、可擴展、高度安全,並提供即時資料訪問,正在為市場成長提供動力。此外,行動 EDC 的引入,利用智慧型手機或平板電腦作為一種方便且經濟高效的方式來收集患者資料,從而提高參與度、提高合規性並降低錯誤風險,有利於市場成長。除此之外,機器學習 (ML) 和人工智慧 (AI) 的整合可改善資料分析、加快決策速度並識別模式、趨勢和異常,這對市場成長產生了積極影響。此外,關於臨床試驗資料的安全性和完整性的嚴格政府法規的實施正在促進對先進資料管理和報告系統的需求,例如 EDC,這有助於確保更好地遵守當局的規定。其他因素,包括對個人化藥物的需求不斷成長、廣泛的研發 (R&D) 活動以及對以患者為中心的臨床試驗的日益關注,預計將推動市場成長。
The global electronic data capture (EDC) systems market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 10.21% during 2024-2032. The rapid digitalization of clinical trials, the rising adoption of the cloud-based system, and the introduction of mobile-EDC represent some of the key factors driving the market.
Electronic data capture (EDC) systems refer to software tools designed to collect and manage clinical trial data in electronic format. They capture a wide variety of data, including patient demographics, medical history, adverse events, laboratory results, clinical outcome assessments, electronic informed consent (eConsent), and study site information. EDC systems are widely used by regulatory agencies, clinical trial sponsors, contract research organizations (CROs), trial participants, and data managers. They help streamline data collection, improve data quality, minimize human errors, protect sensitive information, and reduce the risk of data loss and duplications. EDC systems also enhance the efficiency of the clinical trial, provide real-time monitoring capabilities, assist in decision-making, and ensure data accuracy, reliability, and consistency.
The rapid digitalization of clinical trials across the globe is one of the primary factors propelling the market growth. EDC systems are widely used to automate various clinical trial operations, such as data collection, storage, monitoring, and analysis, which, in turn, accelerate the process, provide transparency, prevent errors, and improve overall efficiency. In addition to this, the growing demand for new treatments and therapeutics due to the increasing prevalence of chronic diseases, such as diabetes, hypertension, Alzheimer's disease, multiple sclerosis, and cardiovascular diseases (CVDs), are acting as another growth-inducing factor. Furthermore, the rising adoption of the cloud-based system, which is cost-effective, user-friendly, scalable, highly secure, and offers real-time access to data, is providing an impetus to the market growth. Additionally, the introduction of mobile-EDC, which utilize smartphones or tablets as a convenient and cost-effective way to collect patients' data, thus improving engagement, increasing compliance, and reducing the risk of errors, is favoring the market growth. Apart from this, the integration of machine learning (ML) and artificial intelligence (AI) to improve data analysis, enable faster decision-making, and identify patterns, trends, and anomalies is positively influencing the market growth. Moreover, the implementation of stringent government regulations regarding the safety and integrity of clinical trial data is facilitating the demand for advanced data management and reporting systems, such as EDC, which aids in ensuring greater compliance with the authorities. Other factors, including increasing demand for personalized medicines, extensive research and development (R&D) activities, and the growing focus on patient-centric clinical trials, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global electronic data capture (EDC) systems market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on delivery mode, component, development phase, and end user.
On-premise
Web & Cloud-based
The report has provided a detailed breakup and analysis of the electronic data capture (EDC) systems market based on the delivery mode. This includes on-premise and web & cloud-based. According to the report, web & cloud-based represented the largest segment.
Software
Services
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the component has also been provided in the report. This includes software and services. According to the report, services accounted for the largest market share.
Phase I
Phase II
Phase III
Phase IV
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the development phase has also been provided in the report. This includes phase I, phase II, phase III, and phase IV. According to the report, phase III accounted for the largest market share.
Hospitals/Healthcare Providers
CROs
Pharmaceutical and Biotechnology Firms
Medical Device Firms
Others
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the end user has also been provided in the report. This includes hospitals/healthcare providers, CROs, pharmaceutical and biotechnology firms, medical device firms, and others. According to the report, CROs accounted for the largest market share.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for electronic data capture (EDC) systems. Some of the factors driving the North America electronic data capture (EDC) systems market included the rising prevalence of chronic diseases, increasing government initiatives, and rapid technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global electronic data capture (EDC) systems market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Anju Software Inc., Calyx, Clario, Datatrak Int, Medidata Solutions Inc., OpenClinica, LLC, Oracle Corporation, Veeva Systems, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.